These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

395 related articles for article (PubMed ID: 34287058)

  • 1. Durable Antibody Responses in Staff at Two Long-Term Care Facilities, during and Post SARS-CoV-2 Outbreaks.
    Gallichotte EN; Nehring M; Young MC; Pugh S; Sexton NR; Fitzmeyer E; Quicke KM; Richardson M; Pabilonia KL; Ehrhart N; Fosdick BK; VandeWoude S; Ebel GD
    Microbiol Spectr; 2021 Sep; 9(1):e0022421. PubMed ID: 34287058
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of Prior Infection on SARS-CoV-2 Antibody Responses in Vaccinated Long-Term Care Facility Staff.
    Gallichotte EN; Nehring M; Stromberg S; Young MC; Snell A; Daniels J; Pabilonia KL; VandeWoude S; Ehrhart N; Ebel GD
    mSphere; 2022 Aug; 7(4):e0016922. PubMed ID: 35862798
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early Adoption of Longitudinal Surveillance for SARS-CoV-2 among Staff in Long-Term Care Facilities: Prevalence, Virologic and Sequence Analysis.
    Gallichotte EN; Quicke KM; Sexton NR; Fitzmeyer E; Young MC; Janich AJ; Dobos K; Pabilonia KL; Gahm G; Carlton EJ; Ebel GD; Ehrhart N
    Microbiol Spectr; 2021 Dec; 9(3):e0100321. PubMed ID: 34756092
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factors associated with SARS-CoV-2 infection and outbreaks in long-term care facilities in England: a national cross-sectional survey.
    Shallcross L; Burke D; Abbott O; Donaldson A; Hallatt G; Hayward A; Hopkins S; Krutikov M; Sharp K; Wardman L; Thorne S
    Lancet Healthy Longev; 2021 Mar; 2(3):e129-e142. PubMed ID: 33655236
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibody Response against SARS-CoV-2 and Seasonal Coronaviruses in Nonhospitalized COVID-19 Patients.
    Ruetalo N; Businger R; Althaus K; Fink S; Ruoff F; Pogoda M; Iftner A; Ganzenmüller T; Hamprecht K; Flehmig B; Bakchoul T; Templin MF; Schindler M
    mSphere; 2021 Feb; 6(1):. PubMed ID: 33627511
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Persistence of Neutralizing Antibodies to SARS-CoV-2 in First Wave Infected Individuals at Ten Months Post-Infection: The UnIRSA Cohort Study.
    Griffante G; Chandel S; Ferrante D; Caneparo V; Capello D; Bettio V; Borgogna C; Aleni C; Esposito S; Sarro A; Vasile A; Comba M; Testa T; Cotrupi G; De Andrea M; Bortoluzzi S; Gariglio M
    Viruses; 2021 Nov; 13(11):. PubMed ID: 34835076
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Seroprevalence of anti-SARS-CoV-2 antibodies in COVID-19 patients and healthy volunteers up to 6 months post disease onset.
    Figueiredo-Campos P; Blankenhaus B; Mota C; Gomes A; Serrano M; Ariotti S; Costa C; Nunes-Cabaço H; Mendes AM; Gaspar P; Pereira-Santos MC; Rodrigues F; Condeço J; Escoval MA; Santos M; Ramirez M; Melo-Cristino J; Simas JP; Vasconcelos E; Afonso Â; Veldhoen M
    Eur J Immunol; 2020 Dec; 50(12):2025-2040. PubMed ID: 33084029
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Non-pharmacological measures implemented in the setting of long-term care facilities to prevent SARS-CoV-2 infections and their consequences: a rapid review.
    Stratil JM; Biallas RL; Burns J; Arnold L; Geffert K; Kunzler AM; Monsef I; Stadelmaier J; Wabnitz K; Litwin T; Kreutz C; Boger AH; Lindner S; Verboom B; Voss S; Movsisyan A
    Cochrane Database Syst Rev; 2021 Sep; 9(9):CD015085. PubMed ID: 34523727
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Persistence of Anti-SARS-CoV-2 Antibodies in Long Term Care Residents Over Seven Months After Two COVID-19 Outbreaks.
    Tanunliong G; Liu A; Vijh R; Pidduck T; Kustra J; Márquez AC; Choi A; McLennan M; Hayden A; Kearney C; Gantt S; Krajden M; Morshed M; Jassem AN; Sekirov I
    Front Immunol; 2021; 12():775420. PubMed ID: 35046939
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sequential Analysis of Binding and Neutralizing Antibody in COVID-19 Convalescent Patients at 14 Months After SARS-CoV-2 Infection.
    Rosati M; Terpos E; Ntanasis-Stathopoulos I; Agarwal M; Bear J; Burns R; Hu X; Korompoki E; Donohue D; Venzon DJ; Dimopoulos MA; Pavlakis GN; Felber BK
    Front Immunol; 2021; 12():793953. PubMed ID: 34899762
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SARS-CoV-2-Specific Neutralizing Antibody Responses in Norwegian Health Care Workers After the First Wave of COVID-19 Pandemic: A Prospective Cohort Study.
    Trieu MC; Bansal A; Madsen A; Zhou F; Sævik M; Vahokoski J; Brokstad KA; Krammer F; Tøndel C; Mohn KGI; Blomberg B; Langeland N; Cox RJ;
    J Infect Dis; 2021 Feb; 223(4):589-599. PubMed ID: 33247924
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epidemiological and Genomic Analysis of a Large SARS-CoV-2 Outbreak in a Long-Term Care Facility in Catalonia, Spain.
    Bordoy AE; Vallès X; Not A; Chiner-Oms Á; Saludes V; Torres Cervós J; Roset Roig A; Juan-Andres C; Sureda H; Pardo-Amil V; García I; Guitart Rossell G; Cambra Cibeira L; Casañ C; Giménez M; Blanco I; Torres-Puente M; Cancino-Muñoz I; González-Candelas F; Comas I; Martró E
    mSphere; 2022 Dec; 7(6):e0034622. PubMed ID: 36448779
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mild SARS-CoV-2 Illness Is Not Associated with Reinfections and Provides Persistent Spike, Nucleocapsid, and Virus-Neutralizing Antibodies.
    Schuler CF; Gherasim C; O'Shea K; Manthei DM; Chen J; Zettel C; Troost JP; Kennedy AA; Tai AW; Giacherio DA; Valdez R; Baldwin JL; Baker JR
    Microbiol Spectr; 2021 Oct; 9(2):e0008721. PubMed ID: 34468184
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sequencing analysis of SARS-CoV-2 cases in Slovenian long-term care facilities to support outbreak control.
    Kogoj R; Grašek M; Suljič A; Zakotnik S; Vlaj D; Kotnik Koman K; Fafangel M; Petrovec M; Avšič-Županc T; Korva M
    Front Public Health; 2024; 12():1406777. PubMed ID: 38813418
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SARS-CoV-2 cases reported from long-term residential facilities (care homes) in South Africa: a retrospective cohort study.
    Arendse T; Cowper B; Cohen C; Masha M; Tempia S; Legodu C; Singh S; Ratau T; Geffen L; Heymans A; Coetzer D; Blumberg L; Jassat W
    BMC Public Health; 2022 May; 22(1):1035. PubMed ID: 35606732
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genomic Epidemiology and Transmission Dynamics of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) in Congregate Healthcare Facilities in Santa Clara County, California.
    MacCannell T; Batson J; Bonin B; Astha KC; Quenelle R; Strong B; Lin W; Rudman SL; Dynerman D; Ayscue P; Han G; Kistler A; Villarino ME;
    Clin Infect Dis; 2022 Mar; 74(5):829-835. PubMed ID: 34328176
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibody response using six different serological assays in a completely PCR-tested community after a coronavirus disease 2019 outbreak-the CoNAN study.
    Weis S; Scherag A; Baier M; Kiehntopf M; Kamradt T; Kolanos S; Ankert J; Glöckner S; Makarewicz O; Hagel S; Bahrs C; Kimmig A; Proquitté H; Guerra J; Rimek D; Löffler B; Pletz MW;
    Clin Microbiol Infect; 2021 Mar; 27(3):470.e1-470.e9. PubMed ID: 33221432
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heterogeneous antibodies against SARS-CoV-2 spike receptor binding domain and nucleocapsid with implications for COVID-19 immunity.
    McAndrews KM; Dowlatshahi DP; Dai J; Becker LM; Hensel J; Snowden LM; Leveille JM; Brunner MR; Holden KW; Hopkins NS; Harris AM; Kumpati J; Whitt MA; Lee JJ; Ostrosky-Zeichner LL; Papanna R; LeBleu VS; Allison JP; Kalluri R
    JCI Insight; 2020 Sep; 5(18):. PubMed ID: 32796155
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early warning and rapid public health response to prevent COVID-19 outbreaks in long-term care facilities (LTCF) by monitoring SARS-CoV-2 RNA in LTCF site-specific sewage samples and assessment of antibodies response in this population: prospective study protocol.
    Lee BE; Sikora C; Faulder D; Risling E; Little LA; Qiu Y; Gao T; Bulat R; Craik S; Hrudey SE; Ohinmaa A; Estabrooks CA; Gingras AC; Charlton C; Kim J; Wood H; Robinson A; Kanji JN; Zelyas N; O'Brien SF; Drews S; Pang XL
    BMJ Open; 2021 Aug; 11(8):e052282. PubMed ID: 34417219
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-Term Elevated Inflammatory Protein Levels in Asymptomatic SARS-CoV-2 Infected Individuals.
    Tserel L; Jõgi P; Naaber P; Maslovskaja J; Häling A; Salumets A; Zusinaite E; Soeorg H; Lättekivi F; Ingerainen D; Soots M; Toompere K; Kaarna K; Kisand K; Lutsar I; Peterson P
    Front Immunol; 2021; 12():709759. PubMed ID: 34603283
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.